The synthesis, hypoglycemic activity and acute toxicity of new imidazole-thiazolidines hybrid structures

V. O. Chornous, O. Ya. Melnyk, O. M. Hliebov, M. V. Tykhonenko, L. M. Sheremeta, O. K. Yarosh, O. M. Denysenko, R. V. Rodik, M. V. Vovk


The article presents a brief description of diabetes type 2 as a disease related with carbohydrate metabolism disorder mainly caused by insulin resistance and relative insulin defi ciency. It has been noted that pathologies may appear under the action of drugs of the glitazone group; it is a major cause for systematic search for new bioactive and safe compounds with the hypoglycemic action. Considering the wide range of the biological activity of imidazole derivatives and 1,3-thiazolidine the synthesis of new hybrid structures – 5-[(1-aryl-4-chloro-1H-imidazole-5-yl)methylene]-1,3-thiazolidine-2,4-diones and their exohydrated analogues – 5-[(1-aryl-4-chloro-1H-imidazole-5-yl)methyl]-1,3-thiazolidine-2,4-diones has been carried out. A preparative suitable scheme for their obtaining has been proposed, it is based on condensation of available 1-aryl-4-chloro-5-formylimidazoles with1,3-thiazolidine-4-one and further hydrogenation of the exocyclic ylidene bond formed. The results of biomedical studies of the compounds obtained in the doses of 100, 10 and 1 mg/kg have shown that they have a strong hypoglycemic activity, which exceeds the effect of test drug pioglitazone by 55%. The acute toxicity (LD50) of 5-{[1-(4-tolyl)-4chloro-1H-imidazole-5-yl]methylene}-1,3-thiazolidine-2,4-dione is 1292.92 mg/k when injected intraperitoneally.


4-chloro-5-formylimidazoles; 1,3-thiazolidine-4-one; imidazole-thiazolidine structure; synthesis; hypo- glycemic activity; acute toxicity


Suntsov Yu. I. Sakharnyi diabet, 2012, No.1, pp.6-11.

Сleary P., Orhard T., Zimman B. Coronary calci™ication in the diabetes control and complication trial (DCCT/EDIC) cohort for the DCCT/EDIC study group program and abstract of ADA 63-rd Annual Scienti™ic Session. New Orlean, Louisiana, 2003.

Yarosh O. K. Farmakologiya ta likarska toksykologiya, 2011, No.5(24), pp.390-392.

Turner R. The Lancet, 1998, Vol. 352, pp.837-852.

Kahn S. E., Zimman B., Lachin J. M. Diabetes Care, 2008,Vol. 31, pp.845-851.

Patel A., MacMahon S., Chalmers J. New England Journal of Medicine, 2008, Vol. 358, pp.2560-2572.

Wilcox R., Kupfer S., Erdman E. American Heart Journal, 2008, Vol. 155, pp.712-717.

Halmann R. R., Paul S. K., Bethel M. A. New England Journal of Medicine, 2008, Vol. 359, pp.1577-1589.

Gaede P., Valentine W. J., Palmer A. J. Diabetes Care, 2008, Vol. 31. pp.1510-1515.

Arner P. Diabetes Obesity Metabolism, 2001, Vol. 3, pp.11-19.

Kendall D. M., Sobel B. E., Coulston A. M., Peters H. A. L., McLean B. K., Peragallo-Dottko V., Buse J. B., Fonseca V. A., Hill J. O., Nesto R. W., Sunyer F. X. Coronary Artery Disease, 2003, Vol. 14, pp.335-348.

Ikeda Н. 36-th Annual Meeting of the European Association for the Study of Diabetes. Report, 2000,3.

Aleksandrov A. A., Kukharenko C. C., Yadrikhinskaya M. H., Shatskaya O. A., Drozdova E. N. Lechashchii vrach, 2012, No.11, pp.23-27.

Inzucchi S. E. Journal of American Medicinal Association, 2002, Vol. 287, No.3, pp.360-372.

Mannuci E., Monami M., Lamonna C., Gensini G. F., Marchioni N. Diabets Obes Metabolism, 2008, Vol. 10, No.12, pp.1221-1235.

Middlemis D., Watson. Tetrahedron, 1994, Vol. 50, No.46, pp.13049-1380.

Narasimphan B., Sharma D., Kumar P. Medicinal Chemistry Research, 2011. Vol. 20, No.8, pp.1119-1140.

Mendgen T., Steuer C., Klein C. D. Journal of Medicinal Chemistry, 2012, Vol. 55, No.2. pp.743-753.

Tomašić T., Mašić L. P. Expert Opinion of on Drug Discovery, 2012, Vol. 7, No.7, pp.549-560.

Chornous V. A., Grozav A. N., Rusanov E. B., Nesterenko A. M., Vovk M. V. Zhurnal Organicheskoi Khimii, 2011, Vol. 47, No.5, pp.699-706.

Stefanov O. V. Doklinochni doslidzhennia likars’kykh zasobiv (metodychni rekomendstsii), K.: Vydavnychyi dim “Avitsenna”, 2001, 528 s.

Montsevichute-Eringene E. V. Patologicheskaya phiziologiya, 1964, No.4. pp.71-78.

GOST Style Citations

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Abbreviated key title: Ž. org. farm. hìm.

ISSN 2518-1548 (Online), ISSN 2308-8303 (Print)